Cardiovascular systems, inc. (CSII)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities
Net loss

-10,601

-7,040

-3,147

-255

2,013

1,706

801

1,712

-1,253

-3,367

-1,911

-1,792

-7,448

-28,415

-44,621

-56,024

-59,809

-47,749

-37,859

-32,822

-33,781

-32,837

-36,222

-35,290

-32,503

-29,010

-26,119

-24,037

-21,801

-19,773

-18,141

-16,790

-14,668

-12,861

-10,716

-11,125

0

0

0

Adjustments to reconcile net loss to net cash from operating activities
Amortization of intangible assets

969

759

477

296

286

210

208

204

-512

-511

-540

218

899

918

952

231

240

233

216

171

132

104

137

124

64

172

64

70

0

0

0

-

-

-

-

-

-

-

-

Depreciation of property and equipment

3,012

3,066

3,089

3,150

3,185

3,319

3,537

3,730

3,912

3,965

3,954

3,917

3,890

3,816

3,756

3,686

3,586

3,209

2,670

2,150

1,640

1,415

1,317

1,243

1,160

979

992

903

819

872

800

817

822

773

719

662

0

0

0

Write-off of patent costs

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

600

475

150

125

0

0

0

-

-

-

415

465

0

0

0

-

0

0

0

-

0

0

0

-

330

255

205

195

0

0

0

-

-

-

-

-

-

-

-

Stock-based compensation

13,135

12,536

12,016

11,266

11,022

10,488

10,388

10,302

9,898

10,161

9,974

10,354

10,921

11,691

12,320

12,977

14,071

14,854

15,252

14,718

14,285

13,156

12,201

10,928

9,808

8,857

7,987

7,442

6,562

5,886

5,464

5,165

5,166

5,282

5,935

6,468

0

0

0

Accretion (Amortization) of Discounts and Premiums, Investments

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on debt, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

137

123

120

-46

-59

-66

-89

-83

-68

0

0

0

-

-

0

0

Debt conversion and valuation of conversion options, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-716

-554

-1,009

-711

-181

-1,715

-58

38

-736

0

0

0

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

0

0

0

Changes in assets and liabilities
Accounts receivable

-3,506

6,402

4,454

4,915

3,154

2,220

3,079

2,878

4,339

2,788

3,423

5,809

5,269

36

-2,206

-7,327

-7,822

138

5,088

10,568

12,523

10,867

7,776

6,718

4,636

3,153

2,009

1,281

2,383

721

1,786

391

-550

1,589

1,041

3,718

0

0

0

Inventories

4,765

1,793

1,394

1,453

2,302

2,278

1,060

-292

397

1,232

148

-543

-1,621

-2,068

1,441

3,474

5,007

4,280

802

1,076

1,330

3,674

6,378

6,647

5,093

3,122

1,304

-818

-1,028

-802

-93

1,243

2,959

3,642

2,599

1,499

0

0

0

Prepaid expenses and other assets

-270

632

458

393

-76

-641

-3,779

-2,308

-1,209

967

3,780

1,823

1,779

-547

-999

-728

-1,005

-647

857

1,183

662

83

-142

564

-208

-150

-535

-925

-288

-149

-141

379

-242

-290

-530

-323

0

0

0

Accounts payable

646

4,496

154

566

2,563

2,191

2,346

104

1,027

2,181

1,733

1,761

620

-912

-695

-970

-1,645

291

-854

581

-761

180

2,463

2,375

4,978

3,665

2,952

1,467

829

-982

91

269

584

1,519

165

1,828

0

0

0

Accrued expenses and other liabilities

-2,128

144

-281

2,918

512

-6

-5,628

-6,577

-6,835

-3,738

1,861

725

-1,283

7,389

4,663

10,873

11,492

3,174

3,839

4,387

8,414

6,354

6,968

6,729

5,180

3,982

1,311

2,481

1,218

666

1,710

7

-1,220

-2,745

-3,162

-2,402

0

0

0

Deferred revenue

-1,827

-1,823

-1,588

-1,884

-1,735

-781

-630

189

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by operating activities

3,876

4,902

5,762

10,208

12,900

14,025

10,900

9,674

4,787

4,941

19,164

19,588

13,100

7,794

-20,823

-23,583

-27,472

-28,795

-22,719

-22,357

-23,627

-25,467

-25,694

-26,838

-19,697

-15,966

-14,591

-10,765

-12,237

-12,435

-11,098

-11,340

-9,678

-11,099

-9,004

-8,361

0

0

0

Cash flows from investing activities
Purchases of property and equipment

2,517

2,751

2,612

2,665

2,628

1,681

1,983

1,956

1,754

1,769

1,268

981

1,414

1,507

2,253

3,818

6,977

11,859

19,191

20,325

28,125

23,258

15,411

12,717

1,972

1,996

1,795

1,672

812

404

505

437

859

848

977

1,081

0

0

0

Payments To Acquire Intangible Assets Purchased

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Debt Securities, Available-for-sale

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

37

55

65

45

2,112

2,094

2,084

2,084

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of convertible note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of marketable securities

4,943

138

99

150

147

195

198

194

190

142

93

46

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs incurred in connection with patents

942

988

1,136

890

898

966

737

1,113

1,228

1,091

1,129

844

797

733

823

813

833

867

1,002

955

871

860

691

702

673

777

747

783

728

717

577

538

519

536

657

656

0

0

0

Net cash provided by (used in) investing activities

-47,067

-55,733

-57,781

-54,352

-8,797

-4,815

-4,742

-5,095

-2,649

-2,575

-2,304

-1,779

-962

-991

-1,847

-3,769

-8,215

-12,776

-20,223

-23,027

-30,725

-26,202

-18,186

-13,419

-2,645

-2,773

-2,542

-2,455

-1,540

-1,121

-1,082

-975

-1,378

-1,384

-1,634

-1,737

0

0

0

Cash flows from financing activities
Payments of employee taxes related to vested restricted stock

6,329

6,299

6,239

1,791

1,708

1,377

1,058

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exercise of stock options

-

-

125

196

196

196

278

513

774

1,501

5,485

5,263

5,002

4,275

1,071

1,006

1,184

2,364

1,488

2,152

2,018

7,959

14,386

16,262

16,800

11,620

8,486

5,927

5,734

4,222

1,203

4,428

0

0

0

-

-

-

-

Payments on borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,400

3,600

5,050

9,850

9,850

9,850

9,600

4,800

4,800

3,600

2,400

2,178

1,935

0

0

0

-

-

-

-

Proceeds from financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,885

0

0

0

-

-

-

-

Proceeds from (Payments for) Other Financing Activities

-76

-63

-50

-36

-24

-10

3

14

24

16

10

4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-2,517

-2,474

-2,412

2,121

1,872

2,217

2,465

3,769

4,037

25,700

29,693

29,465

28,818

7,147

4,213

4,148

4,376

5,556

3,170

2,634

1,858

6,349

97,076

98,952

98,389

136,180

48,147

45,588

61,254

18,221

21,717

26,685

0

0

0

-

-

-

-

Net change in cash and cash equivalents

-45,708

-53,305

-54,431

-42,023

5,975

11,427

8,623

8,348

6,175

28,066

46,553

47,274

40,956

13,950

-18,457

-23,204

-31,311

-36,015

-39,772

-42,750

-52,494

-45,320

53,196

58,695

76,047

117,441

31,014

32,368

47,477

4,665

9,537

14,370

3,837

2,018

670

-2,558

0

0

0

Conversion of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,839

10,370

8,549

5,252

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-